These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
642 related articles for article (PubMed ID: 26160155)
21. The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system. Land BB; Bruchas MR; Lemos JC; Xu M; Melief EJ; Chavkin C J Neurosci; 2008 Jan; 28(2):407-14. PubMed ID: 18184783 [TBL] [Abstract][Full Text] [Related]
22. Intrinsic relative activities of κ opioid agonists in activating Gα proteins and internalizing receptor: Differences between human and mouse receptors. DiMattio KM; Ehlert FJ; Liu-Chen LY Eur J Pharmacol; 2015 Aug; 761():235-44. PubMed ID: 26057692 [TBL] [Abstract][Full Text] [Related]
25. Pharmacological characterization of 2-methyl-N-((2'-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a high-affinity antagonist selective for κ-opioid receptors. Grimwood S; Lu Y; Schmidt AW; Vanase-Frawley MA; Sawant-Basak A; Miller E; McLean S; Freeman J; Wong S; McLaughlin JP; Verhoest PR J Pharmacol Exp Ther; 2011 Nov; 339(2):555-66. PubMed ID: 21821697 [TBL] [Abstract][Full Text] [Related]
26. Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses. Dunn AD; Reed B; Erazo J; Ben-Ezra A; Kreek MJ ACS Chem Neurosci; 2019 Aug; 10(8):3590-3600. PubMed ID: 31313902 [TBL] [Abstract][Full Text] [Related]
27. Structure-Activity Relationships of the Peptide Kappa Opioid Receptor Antagonist Zyklophin. Joshi AA; Murray TF; Aldrich JV J Med Chem; 2015 Nov; 58(22):8783-95. PubMed ID: 26491810 [TBL] [Abstract][Full Text] [Related]
28. Pharmacological characterization of human kappa/mu opioid receptor chimeras that retain high affinity for dynorphin A. DeHaven RN; Mansson E; Daubert JD; Cassel JA Curr Top Med Chem; 2005; 5(3):303-13. PubMed ID: 15857313 [TBL] [Abstract][Full Text] [Related]
34. Comparison of the in vitro efficacy of mu, delta, kappa and ORL1 receptor agonists and non-selective opioid agonists in dog brain membranes. Lester PA; Traynor JR Brain Res; 2006 Feb; 1073-1074():290-6. PubMed ID: 16443205 [TBL] [Abstract][Full Text] [Related]
35. Stress produces aversion and potentiates cocaine reward by releasing endogenous dynorphins in the ventral striatum to locally stimulate serotonin reuptake. Schindler AG; Messinger DI; Smith JS; Shankar H; Gustin RM; Schattauer SS; Lemos JC; Chavkin NW; Hagan CE; Neumaier JF; Chavkin C J Neurosci; 2012 Dec; 32(49):17582-96. PubMed ID: 23223282 [TBL] [Abstract][Full Text] [Related]
36. The endomorphin-1/2 and dynorphin-B peptides display biased agonism at the mu opioid receptor. LaVigne J; Keresztes A; Chiem D; Streicher JM Pharmacol Rep; 2020 Apr; 72(2):465-471. PubMed ID: 32112361 [TBL] [Abstract][Full Text] [Related]
37. Dynorphin peptides differentially regulate the human kappa opioid receptor. Chen Y; Chen C; Liu-Chen LY Life Sci; 2007 Mar; 80(15):1439-48. PubMed ID: 17316701 [TBL] [Abstract][Full Text] [Related]
38. Unique Pharmacological Properties of the Kappa Opioid Receptor Signaling Through G Barnett ME; Knapp BI; Bidlack JM Mol Pharmacol; 2020 Oct; 98(4):462-474. PubMed ID: 32958572 [TBL] [Abstract][Full Text] [Related]
39. Heterodimerization of the kappa opioid receptor and neurotensin receptor 1 contributes to a novel β-arrestin-2-biased pathway. Liu H; Tian Y; Ji B; Lu H; Xin Q; Jiang Y; Ding L; Zhang J; Chen J; Bai B Biochim Biophys Acta; 2016 Nov; 1863(11):2719-2738. PubMed ID: 27523794 [TBL] [Abstract][Full Text] [Related]
40. Structure-activity relationship studies of functionally selective kappa opioid receptor agonists that modulate ERK 1/2 phosphorylation while preserving G protein over βarrestin2 signaling bias. Lovell KM; Frankowski KJ; Stahl EL; Slauson SR; Yoo E; Prisinzano TE; Aubé J; Bohn LM ACS Chem Neurosci; 2015 Aug; 6(8):1411-9. PubMed ID: 25891774 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]